(Q37174994)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18508291%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Host neutralizing responses and pathogenesis of hepatitis C virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18508291%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18508291%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

François-Loic Cosset

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18508291%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

3

Thomas F Baumert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18508291%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18508291%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18508291%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18508291%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18508291%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

299-307

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18508291%20AND%20SRC:MED&resulttype=core&format=json

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

8 January 2020

cites work

1 reference

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

21 January 2018

1 reference

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation

21 January 2018

1 reference

Neutralizing antibodies in hepatitis C virus infection

21 January 2018

1 reference

Role of neutralizing antibodies in protective immunity against HIV.

21 January 2018

1 reference

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

21 January 2018

1 reference

7 January 2021

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

1 reference

7 January 2021

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

1 reference

7 January 2021

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

7 January 2021

Robust hepatitis C virus infection in vitro

1 reference

7 January 2021

Complete replication of hepatitis C virus in cell culture

1 reference

7 January 2021

High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.

1 reference

7 January 2021

Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein

1 reference

7 January 2021

Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus

1 reference

7 January 2021

Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus

1 reference

7 January 2021

Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma

1 reference

7 January 2021

Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins

1 reference

7 January 2021

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

1 reference

7 January 2021

The antiviral activity of antibodies in vitro and in vivo.

1 reference

7 January 2021

Antiviral antibody responses: the two extremes of a wide spectrum

1 reference

7 January 2021

Neutralization of animal virus infectivity by antibody

1 reference

7 January 2021

Humoral immune response in acute hepatitis C virus infection

1 reference

7 January 2021

Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C

1 reference

7 January 2021

Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort

1 reference

7 January 2021

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

1 reference

7 January 2021

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1

1 reference

7 January 2021

Neutralizing antibody response during acute and chronic hepatitis C virus infection

1 reference

7 January 2021

Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.

1 reference

7 January 2021

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

1 reference

7 January 2021

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection

1 reference

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

7 January 2021

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

7 January 2021

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

7 January 2021

Tracking Virus-Specific CD4+ T Cells during and after Acute Hepatitis C Virus Infection

1 reference

7 January 2021

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

7 January 2021

Viral persistence in vivo through selection of neutralizing antibody-escape variants.

1 reference

7 January 2021

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo

1 reference

7 January 2021

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

1 reference

7 January 2021

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

1 reference

7 January 2021

Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy

1 reference

7 January 2021

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

1 reference

7 January 2021

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome

1 reference

7 January 2021

Hepatitis C virus entry: molecular biology and clinical implications

1 reference

7 January 2021

Cell entry of hepatitis C virus

1 reference

7 January 2021

Binding of hepatitis C virus to CD81

1 reference

7 January 2021

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

1 reference

7 January 2021

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate

1 reference

7 January 2021

Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction

1 reference

7 January 2021

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

1 reference

7 January 2021

The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.

1 reference

7 January 2021

Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus

1 reference

7 January 2021

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

1 reference

7 January 2021

The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells

1 reference

7 January 2021

CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection

1 reference

7 January 2021

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.

1 reference

7 January 2021

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity

1 reference

7 January 2021

High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein

1 reference

7 January 2021

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

1 reference

7 January 2021

Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles

1 reference

7 January 2021

Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis

1 reference

7 January 2021

Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

1 reference

7 January 2021

Antibody neutralization and escape by HIV-1

1 reference

7 January 2021

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

1 reference

7 January 2021

Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma

1 reference

7 January 2021

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

1 reference

7 January 2021

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes

1 reference

7 January 2021

Association of hepatitis C virus in human sera with beta-lipoprotein

1 reference

7 January 2021

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

1 reference

7 January 2021

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

1 reference

7 January 2021

The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins.

1 reference

7 January 2021

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

1 reference

7 January 2021

The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.

1 reference

7 January 2021

High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry.

1 reference

7 January 2021

The scavenger receptor BI and its ligand, HDL: partners in crime against HCV neutralizing antibodies

1 reference

7 January 2021

Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization

1 reference

7 January 2021

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

1 reference

7 January 2021

Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites

1 reference

7 January 2021

Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses

1 reference

7 January 2021

Virus entry: open sesame

1 reference

7 January 2021

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

1 reference

7 January 2021

Prospects for a vaccine against the hepatitis C virus

1 reference

7 January 2021

Protection against persistence of hepatitis C.

1 reference

7 January 2021

Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection

1 reference

7 January 2021

Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity

1 reference

7 January 2021

Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge

1 reference

7 January 2021

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

7 January 2021

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees

1 reference

7 January 2021

Engineering of N-glycosylation of hepatitis C virus envelope protein E2 enhances T cell responses for DNA immunization

1 reference

7 January 2021

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

1 reference

7 January 2021

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review

1 reference

7 January 2021

Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: chasing windmills?

1 reference

7 January 2021

Replication of hepatitis C virus

1 reference

7 January 2021